J.C. Vogel et al. / Tetrahedron 64 (2008) 11876–11883
11881
(1H, s, PhCH), 6.94 (2H, d, J¼7.3 Hz, 2ꢂArH), 7.00–7.10 (9H, m,
4.2. General procedure
9ꢂArH), 7.42 (3H, m, 3ꢂArH); 13C NMR (125 MHz, CDCl3)
d 77.9
(PhCH), 80.8 (COH), 121.4 (ArC), 126.2 (ArCH), 127.0 (ArCH), 127.6
(ArCH), 127.8 (ArCH), 127.9 (ArCH), 128.0 (ArCH), 129.1 (ArCH), 131.4
(ArCH), 138.7 (ArC), 143.0 (ArC), 144.3 (ArC); m/z (ESꢁ mode) 481
(Mꢁ, 90%), 403 (10%); Found: (Mꢁ), 481.1196. C26H30O2BrSi requires
SmI2-mediated coupling of aldehydes with 8 or 9 to give
-butyrolactones.
g
To a solution of samarium(II) iodide (0.1 M in THF, 2.2 equiv)
under nitrogen atmosphere at ꢁ15 ꢀC was added dropwise
a mixture of aldehyde (1 equiv), t-BuOH (6 equiv) and 8/9 (1 equiv)
dissolved in THF. The dark blue reaction was stirred for 5 h. The
reaction was quenched with aqueous, saturated NaCl solution
(5 ml) and the aqueous phase was washed with Et2O (3ꢂ5 ml).
The combined organic layers were dried (Na2SO4) and concen-
trated in vacuo. The crude was purified by FSPE to give the lactone
product.
M, 481.1204; nmax (neat) 3427 (br, O–H), 2923 (C–H), 704 cmꢁ1
.
4.1.13. Crotonic acid (1S,2R)-1-{4-[5-(4,4,5,5,6,6,7,7,8,8,9,
9,10,10,11,11,11-heptadecafluoro-undecylsulfanyl)-
pentyl]-phenyl}-1,2-diphenyl (8)
(1R,2S)-[4-(5-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluoro)
decylsulfanylpentyl)-phenyl]-1,2-diphenylethane-1,2-diol 1 (0.73 g,
0.87 mmol), triethylamine (0.17 ml, 1.1 mmol), 4-N-dimethylami-
nopyridine (cat.) and trans-crotonic anhydride (0.175 ml, 1.1 mmol)
in CH2Cl2 (8 ml) were stirred overnight. The product mixture was
washed with aqueous, saturated NaHCO3 (3ꢂ10 ml). The combined
organic layers were dried (Na2SO4) and concentrated in vacuo. The
crude product was purified by FSPE to give 8 (0.599 g, 0.66 mmol,
For the synthesis of the racemic lactone standards for de-
termination of enantiomeric excess using chiral GC, methyl acrylate
and methylcrotonate were used in the above procedure.
4.2.1. (4R,5S)-5-Isopropyl-4-methyl dihydrofuran-2-one6 (10)
See general procedure: the reaction of isobutyraldehyde
(0.017 ml, 0.18 mmol, 1 equiv) with 8 (0.165 g, 0.18 mmol, 1 equiv)
gave, after FSPE, (4R,5S)-5-isopropyl-4-methyl dihydrofuran-2-one
10 (19.1 mg, 75%, 98% ee) as a clear oil. Data is in agreement with
78%) as a white solid. [
a
]D¼90.9ꢀ (c¼0.018, CHCl3); mp 143–145 ꢀC
(MeOH); 1H NMR (500 MHz, CDCl3)
d 1.27–1.29 (2H, m,
ArCH2CH2CH2), 1.50 (4H, m, ArCH2CH2CH2CH2CH2S), 1.75 (3H, dd,
J¼6.6, 1.9 Hz, C(O)CH]CHCH3), 2.29 (2H, m, SCH2CH2RF), 2.42–2.47
(4H, m, ArCH2CH2CH2CH2CH2S), 2.64 (2H, m, SCH2CH2RF), 5.73 (1H,
dd, J¼15.4, 1.9 Hz, C(O)CH]CHCH3), 6.59 (1H, s, PhCH), 6.80–6.87
(3H, m, 2ꢂArH, C(O)CH]CHCH3), 6.97 (2H, m, ArH), 7.03 (2H, m,
ArH), 7.08 (2H, m, ArH), 7.18 (2H, m, ArH), 7.26 (2H, m, ArH), 7.46
that in the literature. 1H NMR (500 MHz, CDCl3)
d 0.91 (3H, d,
J¼6.6 Hz, CH3CHCH3), 1.00 (3H, d, J¼7.0 Hz, CH3CHCH2), 1.09 (3H,
d, J¼6.5 Hz, CH3CHCH3), 1.86–1.93 (1H, m, CH(CH3)2), 2.21 (1H, dd,
J¼16.9 Hz, 1.1 Hz, 1H from CH2C]O), 2.53–2.58 (1H, m,
CHCH2C]O), 2.74 (1H, dd, J¼16.9 Hz, 7.4 Hz, 1H from CH2C]O),
3.94 (1H, dd, J¼10.2 Hz, 4.8 Hz, CHO).
(2H, d, J¼8.2 Hz, ArH); 13C NMR (125 MHz, CDCl3)
d 18.0
(CH3CH]CHC(O)O), 22.6 (SCH2CH2RF), 28.3 (ArCH2CH2CH), 29.2
(CH2CH2S), 30.8 (ArCH2CH2), 32.1 (SCH2CH2RF), 32.2 (CH2S), 35.2
(ArCH2), 78.3 (PhCH), 80.3 (COH), 122.2 (OC(O)CH]CHCH3), 126.3
(ArCH), 126.5 (ArCH), 127.2 (ArCH), 127.3 (ArCH), 127.4 (ArCH), 127.8
(ArCH), 128.2 (ArCH), 128.5 (ArCH), 136.2 (ArC), 140.4 (ArC), 141.1
(ArC), 144.9 (ArC), 145.9 (OC(O)CH]CHCH3), 165.2 (OC]O); m/z
(ESþ mode) 929 (MNa, 100%), 928 (45%), 924 (20%); found: (MNaþ),
929.1931. C39H35O3F17NaS requires M, 929.1928; nmax (neat) 2929,
4.2.2. (S)-5-tert-Butyl-4-methyl dihydrofuran-2-one6 (11)
See general procedure: the reaction of pivaldehyde (0.02 ml,
0.18 mmol, 1 equiv) with 8 (0.165 g, 0.15 mmol, 1 equiv) gave,
after FSPE, (4R,5S)-tert-butyl-4-methyl dihydrofuran-2-one 11
(17.2 mg, 60%, 97% ee) as a clear oil. Data is in agreement with
that in the literature. 1H NMR (500 MHz, CDCl3)
d 1.08 (9H, s,
C(CH3)3), 1.14 (3H, d, J¼7.1 Hz, CH3CH), 2.20 (1H, dd, J¼16.6,
1.6 Hz, 1H from CH2C]O), 2.64–2.69 (1H, m, CHCH2C]O), 2.76
(1H, dd, J¼16.6, 7.6 Hz, 1H from CH2C]O), 4.09 (1H, d, J¼4.9 Hz,
CHO).
1685 (C]O), 1204 (C–F) cmꢁ1
.
4.1.14. Acrylic acid (1S,2R)-1-{4-[5-(4,4,5,5,6,6,7,7,8,8,9,
9,10,10,11,11,11-heptadecafluoro-undecylsulfanyl)-
pentyl]-phenyl}-1,2-diphenyl (9)
4.2.3. (4R,5S)-5-Cyclohexyl-4-methyl dihydrofuran-2-one6 (12)
See general procedure: the reaction of cyclohexyl carbox-
aldehyde (0.02 ml, 0.15 mmol, 1 equiv) with 8 (0.135 g, 0.15 mmol,
1 equiv) gave, after FSPE, (4R,5S)-5-cyclohexyl-4-methyl dihy-
drofuran-2-one 12 (17.5 mg, 82%, 99% ee) as a clear oil. Data is in
agreement with that in the literature. 1H NMR (500 MHz, CDCl3)
(1R,2S)-[4-(5-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadeca-
fluoro)decylsulfanylpentyl)-phenyl]-1,2-diphenylethane-1,2-diol 1
(0.13 g, 0.16 mmol), triethylamine (0.03 ml, 0.25 mmol) and
acryloyl chloride (0.02 ml, 0.22 mmol) in CH2Cl2 (2 ml) was stirred
overnight. The reaction mixture was diluted with CH2Cl2 (5 ml) and
washed with aqueous, saturated NaHCO3 (3ꢂ5 ml). The combined
organic layers were dried (Na2SO4) and concentrated in vacuo.
Purification using FSPE gave 9 (0.094 g, 0.11 mmol, 65%) as a white
d
0.83–0.92 (1H, m, 1H of CH2 of cyclohexane ring), 0.95 (3H, d,
6.9 Hz, CH3CH), 0.99–1.00 (1H, m, 1H of CH2 of cyclohexane ring),
1.07–1.22 (2H, m, CH2 of cyclohexane ring), 1.53–1.58 (3H, m, CH2
and 1H of CH2 of cyclohexane ring), 1.62–1.71 (4H, m, 2ꢂCH2 of
cyclohexane ring),1.96–2.00 (1H, m, 1H of CH2 of cyclohexane ring),
2.12 (1H, dd, J¼16.9 Hz,1.1 Hz, 1H from CH2C]O), 2.47–2.50 (1H, m,
CHCH2C]O), 2.65 (1H, dd, J¼16.9, 7.4 Hz, 1H from CH2C]O), 3.95
(1H, dd, J¼9.8, 4.7 Hz, CHO).
solid. [
a
]D¼81.9ꢀ (c¼0.018, CHCl3); mp 147–150 ꢀC (MeOH); 1H
NMR (500 MHz, CDCl3) d 1.27–1.31 (2H, m, ArCH2CH2CH2), 1.50 (4H,
m, ArCH2CH2CH2CH2CH2S), 2.29 (2H, m, SCH2CH2RF), 2.43–2.47
(4H, m, ArCH2CH2CH2CH2CH2S), 2.64 (2H, m, SCH2CH2RF), 5.80 (1H,
d, J¼10.7 Hz, C(O)CH]CHH), 6.00 (1H, dd, J¼17.0, 10.7 Hz,
C(O)CH]CH2), 6.25 (1H, d, J¼17.0 Hz, C(O)CH]CHH), 6.64 (1H, s,
PhCH), 6.87 (2H, m, ArH), 6.98 (2H, m, ArH), 7.04 (2H, m, ArH), 7.11
(2H, m, ArH), 7.20 (2H, m, ArH), 7.27 (2H, m, ArH), 7.47 (2H, d,
4.2.4. (4R,5S)-5-n-Butyl-4-methyl dihydrofuran-2-one6 (13)
See general procedure: the reaction of valeraldehyde (0.02 ml,
0.18 mmol, 1 eq.) with 8 (0.165 g, 0.18 mmol, 1 equiv) gave, after
FSPE, (4R,5S)-5-n-butyl-4-methyl dihydrofuran-2-one 13 (14.4 mg,
51%, 98% ee) as a clear oil. Data is in agreement with that in the
J¼7.9 Hz, ArH); 13C NMR (125 MHz, CDCl3)
d 22.6 (SCH2CH2RF), 28.3
(ArCH2CH2CH2), 29.2 (CH2CH2S), 30.8 (ArCH2CH2), 32.1
(SCH2CH2RF), 32.2 (CH2S), 35.2 (ArCH2), 78.7 (PhCH), 80.2 (COH),
126.3 (ArCH), 126.5 (ArCH), 127.3 (ArCH),127.4 (ArCH), 127.8 (ArCH),
127.9 (ArCH), 128.0 (C(O)CH]CH2), 128.2 (ArCH), 128.4 (ArCH),
131.6 (C(O)CH]CH2), 135.9 (ArC), 140.3 (ArC), 141.2 (ArC), 144.6
(ArC), 164.9 (OC]O); m/z (ESþ mode) 915 (MNa, 65%), 914 (100%),
921 (10%); found: (MNaþ), 915.1755. C38H33O3F17NaS requires M,
literature. 1H NMR (500 MHz, CDCl3)
d
0.93 (3H, t, J¼7.3 Hz,
CH3CH2), 0.93 (3H, d, J¼7.0 Hz, CHCH3), 1.36–1.42 (3H, m, CH2),
1.45–1.58 (2H, m, CH2), 1.61–1.70 (1H, m, 1H of CH2), 2.21 (1H, dd,
J¼16.9, 3.9 Hz, 1H from CH2C]O), 2.54–2.63 (1H, m, CHCH2C]O),
2.70 (1H, dd, J¼16.9, 7.8 Hz, 1H from CH2C]O), 4.41–4.46 (1H,
m, CHO).
915.1771; nmax (neat) 2929, 1701 (C]O), 1204 (C–F) cmꢁ1
.